BiotechTube
Home/Fimbrion Therapeutics/Thomas J. Hannan
TJ

Thomas J. Hannan

Chief Scientific Officer

Fimbrion Therapeutics

Therapeutic Areas

Infectious DiseaseUrinary Tract InfectionsTuberculosis

Fimbrion Therapeutics Pipeline

DrugIndicationPhase
UTI Program (with GSK)Treatment & Prevention of Recurrent Urinary Tract InfectionsPhase 1
Tuberculosis ProgramTuberculosisPreclinical

Leadership Team at Fimbrion Therapeutics

SJ
Scott J. Hultgren
Co-Founder, Board Member
JW
James W. Janetka
Co-Founder, Board Member
TM
Thomas M. Hooton
Co-Founder, Board Member
CL
Christina L. Stallings
Board Member
View full Fimbrion Therapeutics profile